Abbott Laboratories (ABT) Other Non-Current Assets (2009 - 2020)

Abbott Laboratories' Other Non-Current Assets history runs 12 years deep, the most recent figure standing at $824.0 million for Q4 2020.

• In Q4 2020, Other Non-Current Assets rose 19.94% year-over-year to $824.0 million; the TTM figure through Dec 2020 stood at $824.0 million (up 19.94% YoY), while the FY2020 annual figure was $824.0 million, up 19.94% from the prior year.
• Other Non-Current Assets came in at $824.0 million for Q4 2020 at Abbott Laboratories, up from $687.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $2.8 billion in Q4 2016 to a low of $2.0 million in Q1 2016.
• A 5-year average of $647.2 million and a median of $148.5 million in 2017 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets surged 2521.9% in 2016 and plunged 97.74% in 2017, its largest moves.
• Abbott Laboratories' Other Non-Current Assets stood at $2.8 billion in 2016, then slumped by 93.61% to $176.0 million in 2017, then jumped by 231.25% to $583.0 million in 2018, then advanced by 17.84% to $687.0 million in 2019, then climbed by 19.94% to $824.0 million in 2020.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $824.0 million, $687.0 million, and $583.0 million for Q4 2020, Q4 2019, and Q4 2018 respectively.

Peer Comparison